Article

Detecting hidden threats using longitudinal liquid biopsies

2025-09-08

Abstract excerpt

<title>Abstract</title> <p> Multicancer early detection (MCED) assays aim to detect cancers while still asymptomatic and, hopefully, more likely to be curable. To understand how long an MCED assay is interpretable before the emergence of symptoms and how frequently the test should be repeated after a negative result, we mined a surrogate dataset from a longitudinal liquid biopsy program monitoring patients with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3c988170-7585-56ac-ad71-8595acae17c9
DOI: 10.21203/rs.3.rs-7395993/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Detecting hidden threats using longitudinal liquid biopsiesDOI 10.21203/rs.3.rs-7395993/v1Read

Liquid biopsy in prostate cancer: A novel dual biomarker analysis approach integrating circulating tumor cells and circulating tumor DNA data.Semantic proximity Read

Evaluating the role of liquid biopsy to detect pathogenic DNA Damage Repair (DDR) gene alterations in metastatic prostate cancerSemantic proximity Read

Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer.Semantic proximity Read

Unlocking the Genetic Enigma: Estimating the Hidden Horde of Barcoded Cancer Cells using a Molecular German Tank Problem ApproachSemantic proximity Read

Incidental detection of FGFR3 fusion via liquid biopsy leading to earlier diagnosis of urothelial carcinomaSemantic proximity Read

Lesion Shedding Model: unraveling site-specific contributions to ctDNA.Semantic proximity Read

Advancements in Early Cancer Detection: Toward Integrated, Longitudinal Precision ScreeningSemantic proximity Read

Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA Profiling.Semantic proximity Read

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable AlterationsSemantic proximity Read

Practical Utility of Liquid Biopsy for Evaluating Genomic Alterations in Castration-Resistant Prostate CancerSemantic proximity Read

Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.Semantic proximity Read

Study Design and Interim Analysis of the Cancer Lifetime Assessment Screening Study in Canines (CLASSiC): The First Prospective Cancer Screening Study in Dogs Using Next-Generation Sequencing-Based Liquid BiopsySemantic proximity Read